Microbiota and Complications in Kidney Transplant Recipients

Request Access

Biomarkers (2)

CKD_STAGE - CKD stage at 1 month post-transplantation (phv00418152.v2.p1)
Final_Cause_ESRD - Cause of end stage renal disease (phv00418028.v2.p1)

Demographics (2)

AGE - Age of Subject at Kidney Transplantation (Except for JL.132 which is the age at consent) (phv00418013.v2.p1)
SEX - Sex of Subject (phv00525985.v1.p1)

Disease Events (1)

DM - History of Diabetes Mellitus (phv00418018.v2.p1)

Medications (40)

Abx_Post_Op_Day1 - Post-Transplant Day Antibiotic #1 if given (phv00418100.v2.p1)
Abx_Post_Op_Day10 - Post-Transplant Day Antibiotic #10 if given (phv00418118.v2.p1)
Abx_Post_Op_Day11 - Post-Transplant Day Antibiotic #11 if given (phv00418120.v2.p1)
Abx_Post_Op_Day12 - Post-Transplant Day Antibiotic #12 if given (phv00418122.v2.p1)
Abx_Post_Op_Day13 - Post-Transplant Day Antibiotic #13 if given (phv00418124.v2.p1)
Abx_Post_Op_Day14 - Post-Transplant Day Antibiotic #14 if given (phv00418126.v2.p1)
Abx_Post_Op_Day15 - Post-Transplant Day Antibiotic #15 if given (phv00418128.v2.p1)
Abx_Post_Op_Day16 - Post-Transplant Day Antibiotic #16 if given (phv00418130.v2.p1)
Abx_Post_Op_Day17 - Post-Transplant Day Antibiotic #17 if given (phv00418132.v2.p1)
Abx_Post_Op_Day2 - Post-Transplant Day Antibiotic #2 if given (phv00418102.v2.p1)
Abx_Post_Op_Day3 - Post-Transplant Day Antibiotic #3 if given (phv00418104.v2.p1)
Abx_Post_Op_Day4 - Post-Transplant Day Antibiotic #4 if given (phv00418106.v2.p1)
Abx_Post_Op_Day5 - Post-Transplant Day Antibiotic #5 if given (phv00418108.v2.p1)
Abx_Post_Op_Day6 - Post-Transplant Day Antibiotic #6 if given (phv00418110.v2.p1)
Abx_Post_Op_Day7 - Post-Transplant Day Antibiotic #7 if given (phv00418112.v2.p1)
Abx_Post_Op_Day8 - Post-Transplant Day Antibiotic #8 if given (phv00418114.v2.p1)
Abx_Post_Op_Day9 - Post-Transplant Day Antibiotic #9 if given (phv00418116.v2.p1)
Abx_Type1 - Antibiotic Type #1 (if given to subject) (phv00418099.v2.p1)
Abx_Type10 - Antibiotic Type #10 (if given to subject) (phv00418117.v2.p1)
Abx_Type11 - Antibiotic Type #11 (if given to subject) (phv00418119.v2.p1)
Abx_Type12 - Antibiotic Type #12 (if given to subject) (phv00418121.v2.p1)
Abx_Type13 - Antibiotic Type #13 (if given to subject) (phv00418123.v2.p1)
Abx_Type14 - Antibiotic Type #14 (if given to subject) (phv00418125.v2.p1)
Abx_Type15 - Antibiotic Type #15 (if given to subject) (phv00418127.v2.p1)
Abx_Type16 - Antibiotic Type #16 (if given to subject) (phv00418129.v2.p1)
Abx_Type17 - Antibiotic Type #17 (if given to subject) (phv00418131.v2.p1)
Abx_Type2 - Antibiotic Type #2 (if given to subject) (phv00418101.v2.p1)
Abx_Type3 - Antibiotic Type #3 (if given to subject) (phv00418103.v2.p1)
Abx_Type4 - Antibiotic Type #4 (if given to subject) (phv00418105.v2.p1)
Abx_Type5 - Antibiotic Type #5 (if given to subject) (phv00418107.v2.p1)
Abx_Type6 - Antibiotic Type #6 (if given to subject) (phv00418109.v2.p1)
Abx_Type7 - Antibiotic Type #7 (if given to subject) (phv00418111.v2.p1)
Abx_Type8 - Antibiotic Type #8 (if given to subject) (phv00418113.v2.p1)
Abx_Type9 - Antibiotic Type #9 (if given to subject) (phv00418115.v2.p1)
BACTRIM - Pneumocystis jirovecii prophylaxis (phv00418024.v2.p1)
BACTRIM_2 - Pneumocystis jirovecii prophylaxis in more details (phv00418025.v2.p1)
Cellcept_Dosage_Week_1 - Dosage of mycophenolate mofetil (1000 mg BID equivalent or 500 mg BID equivalent) (phv00525989.v1.p1)
PREDNISONE - Steroid Maintenance (phv00418026.v2.p1)
PREOP_ABX - Preoperative antibiotic prophylaxis (phv00418020.v2.p1)
PREOP_ABX_2 - Preoperative antibiotic prophylaxis in more details (phv00418021.v2.p1)

Race and Ethnicity (1)

RACE - Subject Race (phv00418015.v2.p1)

Other (113)

Biofire_Panel_Positive_Week_1 - Biofire PCR Assay Results (phv00525986.v1.p1)
BK_DAY_12 - Last Day of Follow up for BK viremia status (12 month time point) (phv00418148.v2.p1)
BK_DAY_24 - Last Day of Follow up for BK viremia status (24 month time point) (phv00418150.v2.p1)
BK_DAY_6 - Last Day of Follow up for BK viremia status ( 6 month time point) (phv00418146.v2.p1)
BK_STATUS_12 - BK viremia status of subject (12 month time point) (phv00418147.v2.p1)
BK_STATUS_24 - BK viremia status of subject (24 month time point) (phv00418149.v2.p1)
BK_STATUS_6 - BK viremia status of subject (6 month time point) (phv00418145.v2.p1)
BUTYRATE_STUDY - Subject Part of Butyrate Study (phv00418154.v2.p1)
Cdiff_Positive_Week_1 - Cdiff (Biofire) PCR Assay Results (phv00525987.v1.p1)
CMV_DAY_12 - Last Day of Follow up for CMV viremia status (12 month time point) (phv00418142.v2.p1)
CMV_DAY_24 - Last Day of Follow up for CMV viremia status (24 month time point) (phv00418144.v2.p1)
CMV_DAY_6 - Last Day of Follow up for CMV viremia status ( 6 month time point) (phv00418140.v2.p1)
CMV_RISK - CMV Donor Antibody Recipient Antibody Risk (phv00418151.v2.p1)
CMV_STATUS_12 - CMV viremia status of subject (12 month time point) (phv00418141.v2.p1)
CMV_STATUS_24 - CMV viremia status of subject (24 month time point) (phv00418143.v2.p1)
CMV_STATUS_6 - CMV viremia status of subject (6 month time point) (phv00418139.v2.p1)
CONSENT - Consent group as determined by DAC (phv00418009.v2.p1)
Culture1 - Detected Organism #1 (if detected) (phv00418043.v2.p1)
Culture10 - Detected Organism #10 (if detected) (phv00418070.v2.p1)
Culture11 - Detected Organism #11 (if detected) (phv00418073.v2.p1)
Culture12 - Detected Organism #12 (if detected) (phv00418076.v2.p1)
Culture13 - Detected Organism #13 (if detected) (phv00418079.v2.p1)
Culture14 - Detected Organism #14 (if detected) (phv00418082.v2.p1)
Culture15 - Detected Organism #15 (if detected) (phv00418085.v2.p1)
Culture16 - Detected Organism #16 (if detected) (phv00418088.v2.p1)
Culture17 - Detected Organism #17 (if detected) (phv00418091.v2.p1)
Culture18 - Detected Organism #18 (if detected) (phv00418094.v2.p1)
Culture19 - Detected Organism #19 (if detected) (phv00418097.v2.p1)
Culture2 - Detected Organism #2 (if detected) (phv00418046.v2.p1)
Culture3 - Detected Organism #3 (if detected) (phv00418049.v2.p1)
Culture4 - Detected Organism #4 (if detected) (phv00418052.v2.p1)
Culture5 - Detected Organism #5 (if detected) (phv00418055.v2.p1)
Culture6 - Detected Organism #6 (if detected) (phv00418058.v2.p1)
Culture7 - Detected Organism #7 (if detected) (phv00418061.v2.p1)
Culture8 - Detected Organism #8 (if detected) (phv00418064.v2.p1)
Culture9 - Detected Organism #9 (if detected) (phv00418067.v2.p1)
DDRT - Type of Transplant (phv00418016.v2.p1)
DGF - Delayed Graft Function (phv00418019.v2.p1)
Diarrhea_Future_3_Months - Future Development of Diarrhea in 3 months post transplantation (phv00525988.v1.p1)
ECOLI_BACTERIURIA_LAST_FOLLOW_UP - Last Day of Follow up for Escherichia bacteriuria status (phv00418035.v2.p1)
ECOLI_BACTERIURIA_STATUS - Escherichia bacteriuria status of subject (phv00418034.v2.p1)
ECOLI_UTI_LAST_FOLLOW_UP - Last Day of Follow up for Escherichia UTI status (phv00418039.v2.p1)
ECOLI_UTI_STATUS - Escherichia UTI status of subject (phv00418038.v2.p1)
ENTEROCOCCUS_BACTERIURIA_LAST_FOLLOW_UP - Last Day of Follow up for Enterococcus bacteriuria status (phv00418037.v2.p1)
ENTEROCOCCUS_BACTERIURIA_STATUS - Enterococcus bacteriuria status of subject (phv00418036.v2.p1)
ENTEROCOCCUS_UTI_LAST_FOLLOW_UP - Last Day of Follow up for Enterococcus UTI status (phv00418041.v2.p1)
ENTEROCOCCUS_UTI_STATUS - Enterococcus UTI status of subject (phv00418040.v2.p1)
GUS_subgroup_analysis - Patients with or without diarrhea in GUS subgroup analysis (phv00525991.v1.p1)
GUS_value - Betaglucuronidase (GUS) activity in stool (phv00525993.v1.p1)
LK - Simultaneous liver kidney transplantation (phv00418030.v2.p1)
Post_Op_Day - Day Sample was Obtained from Subject in Relationship to Transplant Event (phv00418156.v2.p1)
Post_Tx_Day1 - Post-Transplant Day Organism #1 detected (phv00418044.v2.p1)
Post_Tx_Day10 - Post-Transplant Day Organism #10 detected (phv00418071.v2.p1)
Post_Tx_Day11 - Post-Transplant Day Organism #11 detected (phv00418074.v2.p1)
Post_Tx_Day12 - Post-Transplant Day Organism #12 detected (phv00418077.v2.p1)
Post_Tx_Day13 - Post-Transplant Day Organism #13 detected (phv00418080.v2.p1)
Post_Tx_Day14 - Post-Transplant Day Organism #14 detected (phv00418083.v2.p1)
Post_Tx_Day15 - Post-Transplant Day Organism #15 detected (phv00418086.v2.p1)
Post_Tx_Day16 - Post-Transplant Day Organism #16 detected (phv00418089.v2.p1)
Post_Tx_Day17 - Post-Transplant Day Organism #17 detected (phv00418092.v2.p1)
Post_Tx_Day18 - Post-Transplant Day Organism #18 detected (phv00418095.v2.p1)
Post_Tx_Day19 - Post-Transplant Day Organism #19 detected (phv00418098.v2.p1)
Post_Tx_Day2 - Post-Transplant Day Organism #2 detected (phv00418047.v2.p1)
Post_Tx_Day3 - Post-Transplant Day Organism #3 detected (phv00418050.v2.p1)
Post_Tx_Day4 - Post-Transplant Day Organism #4 detected (phv00418053.v2.p1)
Post_Tx_Day5 - Post-Transplant Day Organism #5 detected (phv00418056.v2.p1)
Post_Tx_Day6 - Post-Transplant Day Organism #6 detected (phv00418059.v2.p1)
Post_Tx_Day7 - Post-Transplant Day Organism #7 detected (phv00418062.v2.p1)
Post_Tx_Day8 - Post-Transplant Day Organism #8 detected (phv00418065.v2.p1)
Post_Tx_Day9 - Post-Transplant Day Organism #9 detected (phv00418068.v2.p1)
PRA_status - Calculated panel reactive antibody status (>= 80 percent) (phv00418027.v2.p1)
PRIORTX - History of Prior Transplantation (phv00418017.v2.p1)
PROLONGED_FOLEY - Prolonged foley catheter or intermittent catheterization (phv00418033.v2.p1)
RV_DAY_12 - Last Day of Follow up for respiratory virus status (12 month time point) (phv00418136.v2.p1)
RV_DAY_24 - Last Day of Follow up for respiratory virus status (24 month time point) (phv00418138.v2.p1)
RV_DAY_6 - Last Day of Follow up for respiratory virus status ( 6 month time point) (phv00418134.v2.p1)
RV_STATUS_12 - Respiratory virus status of subject (12 month time point) (phv00418135.v2.p1)
RV_STATUS_24 - Respiratory virus status of subject (24 month time point) (phv00418137.v2.p1)
RV_STATUS_6 - Respiratory virus status of subject (6 month time point) (phv00418133.v2.p1)
SAMPLE_ID - Sample ID (phv00418155.v2.p1)
SAMPLE_ID - Sample ID (phv00418011.v2.p1)
Sample_Type - Type of Sample obtained (urine vs stool) (phv00418157.v2.p1)
Sample1 - Type of Culture (phv00418042.v2.p1)
Sample10 - Type of Culture (phv00418069.v2.p1)
Sample11 - Type of Culture (phv00418072.v2.p1)
Sample12 - Type of Culture (phv00418075.v2.p1)
Sample13 - Type of Culture (phv00418078.v2.p1)
Sample14 - Type of Culture (phv00418081.v2.p1)
Sample15 - Type of Culture (phv00418084.v2.p1)
Sample16 - Type of Culture (phv00418087.v2.p1)
Sample17 - Type of Culture (phv00418090.v2.p1)
Sample18 - Type of Culture (phv00418093.v2.p1)
Sample19 - Type of Culture (phv00418096.v2.p1)
Sample2 - Type of Culture (phv00418045.v2.p1)
Sample3 - Type of Culture (phv00418048.v2.p1)
Sample4 - Type of Culture (phv00418051.v2.p1)
Sample5 - Type of Culture (phv00418054.v2.p1)
Sample6 - Type of Culture (phv00418057.v2.p1)
Sample7 - Type of Culture (phv00418060.v2.p1)
Sample8 - Type of Culture (phv00418063.v2.p1)
Sample9 - Type of Culture (phv00418066.v2.p1)
Severity_diarrhea - Of patients with diarrhea, whether the diarrhea is severe or not (phv00525992.v1.p1)
SPK - Simultaneous pancreas kidney transplantation (phv00418029.v2.p1)
STENT - Ureteral stent placed during transplant surgery (phv00418032.v2.p1)
SUBJECT_ID - Subject ID (phv00418012.v2.p1)
SUBJECT_ID - Subject ID (phv00418008.v2.p1)
SUBJECT_ID - Subject ID (phv00418010.v2.p1)
Symptomatic_UTI - Escherichia Urine Sample associated with symptoms of UTI (phv00418158.v2.p1)
TACRO - On tacrolimus maintenance therapy (phv00418031.v2.p1)
THYMO - Induction therapy (phv00418022.v2.p1)
THYMO_2 - Induction therapy in more details (phv00418023.v2.p1)
UTI_STUDY - Subject Part of Urinary Tract Infection Study (phv00418153.v2.p1)
Validation_Diarrhea_Group - Part of Validation Study - Diarrhea Status (Clin Transplant Zhang et al., 2021) (phv00525990.v1.p1)